Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
Abstract Cystic fibrosis (CF) is a multisystem disorder, caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. These cause a reduced secretion of chloride, a marked absorption of sodium and, therefore, of water, through the epithelium, resulting in the formation of thickened...
Saved in:
Main Authors: | Vito Terlizzi (Author), Eleonora Masi (Author), Michela Francalanci (Author), Giovanni Taccetti (Author), Diletta Innocenti (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bronchial reactivity to inhaled hypertonic saline solutions in children with cystic fibrosis
by: S.I. Ilchenko, et al.
Published: (2022) -
Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
by: Vito Terlizzi, et al.
Published: (2022) -
Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
by: Matteo Botti, et al.
Published: (2021) -
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021) -
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial
by: Raffaella Nenna, et al.
Published: (2017)